GALT PHARMACEUTICALS Trademark

Trademark Overview


On Friday, June 23, 2017, a trademark application was filed for GALT PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the GALT PHARMACEUTICALS trademark a serial number of 87502346. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, August 4, 2025. This trademark is owned by Galt Pharmaceuticals, LLC. The GALT PHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

line of medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, pharmaceutical preparations for treating insomnia and sleep disorders, clinical depression, symptoms of Osteoarthritis and Rheumatoid Arthritis, acute pain, musculoskeletal disorders, infections, skin irritations, diabetes, vestibular disorders, gastrointestinal disorders, inflammation, and mental health disorders

Wholesale store services featuring pharmaceuticals; distributorships in the field of prescription drug and pharmaceutical products
galt pharmaceuticals

General Information


Serial Number87502346
Word MarkGALT PHARMACEUTICALS
Filing DateFriday, June 23, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, August 4, 2025
Registration Number5592063
Registration DateTuesday, October 23, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the wording "GALT PHARMACEUTICALS" with horizontal lines appearing above and below the word "PHARMACEUTICALS". "GALT" appears in blue and black above the word "PHARMACEUTICALS". The remainder of the mark is black.
Goods and Servicesline of medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, pharmaceutical preparations for treating insomnia and sleep disorders, clinical depression, symptoms of Osteoarthritis and Rheumatoid Arthritis, acute pain, musculoskeletal disorders, infections, skin irritations, diabetes, vestibular disorders, gastrointestinal disorders, inflammation, and mental health disorders
Indication of Colors claimedThe color(s) blue and black is/are claimed as a feature of the mark.
Goods and ServicesWholesale store services featuring pharmaceuticals; distributorships in the field of prescription drug and pharmaceutical products
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code005
First Use Anywhere DateWednesday, December 7, 2016
First Use In Commerce DateWednesday, December 7, 2016

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, June 30, 2017
Primary Code035
First Use Anywhere DateMonday, May 8, 2017
First Use In Commerce DateFriday, June 15, 2018

Trademark Owner History


Party NameGalt Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Party NameGalt Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339

Trademark Events


Event DateEvent Description
Friday, September 15, 2017NON-FINAL ACTION WRITTEN
Tuesday, June 27, 2017NEW APPLICATION ENTERED
Friday, June 30, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 1, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 14, 2017ASSIGNED TO EXAMINER
Tuesday, August 14, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, September 15, 2017NON-FINAL ACTION E-MAILED
Friday, September 15, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 23, 2018ASSIGNED TO LIE
Tuesday, February 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 27, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 17, 2018FINAL REFUSAL WRITTEN
Saturday, March 17, 2018FINAL REFUSAL E-MAILED
Saturday, March 17, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, September 6, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, September 11, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, August 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 6, 2018TEAS AMENDMENT OF USE RECEIVED
Thursday, September 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 11, 2018USE AMENDMENT FILED
Tuesday, September 11, 2018AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, September 11, 2018USE AMENDMENT ACCEPTED
Wednesday, September 19, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 14, 2025POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, September 12, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, October 23, 2018REGISTERED-SUPPLEMENTAL REGISTER
Monday, October 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 3, 2024TEAS SECTION 8 RECEIVED
Monday, August 4, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, August 4, 2025NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, July 23, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED